BridgeBio Pharma Overview
BridgeBio Pharma Target Price
Analysts' 12-month price predictions for BBIO.
Share Price
$51.83
Average Target Price
$70.00
35.1% upside
35.1% upside1 analysts in the last 4 months
High: $70 | Low: $70
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-08-29 | H.C. WainwrightRaghuram Selvaraju | $70 | 35.1% upside |  |
| 2025-04-30 | UBSEliana Merle | $72 | 38.9% upside | |
| 2024-10-24 | CitigroupDavid Lebowitz | $45 |  13.2% downside | |
| 2024-10-17 | Leerink PartnersMani Foroohar | $46 | 11.2% downside | |
| 2024-09-11 | Piper SandlerBiren Amin | $46 | 11.2% downside | |
| 2024-09-03 | Mizuho SecuritiesSalim Syed | $53 | 2.3% upside | |
| 2024-06-24 | Raymond JamesDanielle Brill | $46 | 11.2% downside | |
| 2024-06-05 | BMO CapitalKostas Biliouris | $37 | 28.6% downside | |
| 2024-06-05 | Wells FargoTiago Fauth | $58 | 11.9% upside | |
| 2024-05-30 | Goldman SachsPaul Choi | $50 | 3.5% downside | |
| 2024-05-28 | UBSEliana Merle | $47 | 9.3% downside | |
| 2024-05-20 | H.C. WainwrightRaghuram Selvaraju | $43 | 17% downside | |
| 2024-05-13 | Evercore ISICory Kasimov | $50 | 3.5% downside | |
| 2022-11-18 | J.P. Morgan | $19 | 63.3% downside | |
| 2022-03-17 | Raymond JamesDane Leone | $17 | 67.2% downside | |